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Abstract
Background: In the present study we analyze the relationship between body mass index (BMI) and waist circumference
(WC) and future health care costs. On the basis of the relation between these anthropometric measures and mortality, we
hypothesized that for all levels of BMI increased WC implies added future health care costs (Hypothesis 1) and for given
levels of WC increased BMI entails reduced future health care costs (Hypothesis 2). We furthermore assessed whether a
combination of the two measures predicts health care costs better than either individual measure.
Research Methodology/Principal Findings: Data were obtained from the Danish prospective cohort study Diet, Cancer and
Health. The population includes 15,334 men and 16,506 women 50 to 64 years old recruited in 1996 to 1997. The
relationship between future health care costs and BMI and WC in combination was analyzed by use of categorized and
continuous analyses. The analysis confirms Hypothesis 1, reflecting that an increased level of abdominal fat for a given BMI
gives higher health care costs. Hypothesis 2, that BMI had a protective effect for a given WC, was only confirmed in the
continuous analysis and for a subgroup of women (BMI,30 kg/m
2 and WC ,88 cm). The relative magnitude of the
estimates supports that the regressions including WC as an explanatory factor provide the best fit to the data.
Conclusion: The study showed that WC for given levels of BMI predicts increased health costs, whereas BMI for given WC
did not predict health costs except for a lower cost in non-obese women with normal WC. Combining WC and BMI does not
give a better prediction of costs than WC alone.
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Introduction
In epidemiologic research on obesity it is debated whether a
combined use of waist circumference (WC) and Body Mass Index
(BMI) is a better instrument for identifying high risk individuals
[1;2]. The reasons for this increased focus are that numerous
studies have shown the importance of the body fat distribution as a
health risk factor [3], and, secondly, the fact that BMI and WC
reflect different body compositions-particularly at the lower end of
their distributions. BMI is a proxy measure of total body fat and
not fat distribution, whereas WC is a proxy measure of abdominal
fat mass [4]. Therefore, the argument has been that a combination
of the two measures will represent a better predictor of the
variation in health risk.
Bigaard et al. have recently emphasized the importance of using
both BMI and WC as a predictor of all cause mortality [1]. Only a
few studies have focused on morbidity in general in the
investigation of the combined use of BMI and WC in the
identification of high-risk individuals, and the available studies
focus on one co-morbidity at a time [5–10]. This is probably due
to the complexity of the problem, which involves a wide range of
obesity-related diseases. In addition, previous economic studies of
the excess health care costs associated with obesity have applied
either BMI or WC as the obesity measures [11–19].
The existing economic studies report that health care costs
increase with increased obesity status [11–19]. In view of the
distinct differences in the associations between BMI and mortality
and between WC and mortality, when conditioned on each other
[1], it would be relevant to investigate whether the combined use
of WC and BMI improves the identification of high costs
individuals. The mortality associations have their basis in
underlying morbidity, but will only partially reflect the overall
morbidity problems of obesity, because they involve several health
problems not associated with increased mortality, e.g. chronic
musculoskeletal disorders.
In the present study we analyze the relationship between future
health care costs and the BMI and WC in combination assessed at
one point in time. Future health care costs may be interpreted as a
measure of the intensity of contacts with the health care sector and
may hence be seen as a proxy for morbidity. Clearly, morbidity
does not necessarily incur need for health care services if
treatments are not available, offered or needed. Also, severity of
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theless, one would assume a strong correlation between morbidity
and health care consumption. The advantage of applying health
care consumption as a measure of morbidity is that it requires no a
priori definitions of what constitutes obesity related diseases. This
measure consequently implicitly constitutes a broad and uncon-
strained definition of obesity-related morbidity.
We hypothesized that for all levels of BMI, increased WC
implies added health care costs (Hypothesis 1). Second, we
expected that BMI has a protective effect and that for given levels
of WC increased BMI implies reduced health care costs
(Hypothesis 2). Third, we assessed whether the prediction of
future health care costs was improved by combining the two
measures compared to using them separately.
Methods
Research Methods and Procedures
Data were obtained from the Danish prospective cohort study
Diet, Cancer and Health (DCH) [20]. The population of the DCH
study constituted individuals born in Denmark, aged 50–64 years
at baseline, residents in the greater Copenhagen or Aarhus areas,
and had no records of cancer in the Danish Cancer register at the
time of selection [20]. The baseline health status screening was
conducted between December 1993 and May 1997 and includes:
Anthropometric measurements, blood pressure, collection of
biological material, questions on diet and lifestyle. Details of the
cohort study have been described previously [20].
A total of 160,725 individuals were invited to participate in the
DCH study and of these a total of 55,705 participated in the study.
Only individuals included in DCH in the period January 1996 and
May 1997 were included in the present study, due to constraints
on the accessibility of uniform costs data (reporting procedures
varied in the previous time period). Health status, lifestyle and
socioeconomic variables were assessed at base-line while individual
data on health care consumption and associated costs were
extracted for the subsequent 7 years (1996/1997 to 2003/2004).
Health Care Costs
Only direct public health care costs were included in the analyses.
The health care system in Denmark is predominantly publicly
financed by income taxes and other taxes, and all public health care
services are registered in various registers. All Danish residents have
a 10-digit individual identification number (CPR number) which
enables identification of resource consumption at the individual
level. For each study subject, the following information on health
care use was obtained: (I) somatic in- and out-patient treatments
(retrieved from the National Patient Register), (II) psychiatric in- and
out-patient treatments (retrieved from the Danish Psychiatric central
Register [21]) (III) primary sector health care services, including
general practitioners, practicing specialists, dentists, physiotherapists,
psychologists etc. (retrieved from the National health Insurance
Register) and (IV) prescription drugs entitled to a subsidy (retrieved
from the national medicine database).
The Danish Case Mix System (Diagnostic related groups; DRG)
was used to assign costs to all somatic outpatient and inpatient
services. Since DRG charges are only available for somatic
services, the National Board of Health’s per diem charge and
ambulant charge for psychiatric treatments were used to calculate
the cost of psychiatric treatment. The cost of primary sector health
care services was estimated by using the refunding price plus the
patient’s costs (for some of the services in the primary sector only a
part of the total cost is refunded). The retail cost at the date of
purchase was used to assign cost of prescription drugs.
The costs were adjusted to 2005 price level and aggregated at
the individual level. The mean annual health care cost per subject
was calculated by dividing the total costs by the number of person
years registered in the 7 year follow up period. In the following we
refer to this figure as future health care costs. The results are
presented in US$ (Danish kroner (DKK) and converted to US$
using currency rate 100 DKK=US$17.40).
Statistical analyses
In order to eliminate potential sources of bias due to
confounding factors such as illness related weight loss, the analyses
were restricted to individuals with a BMI of 18.50 kg/m
2 or more
and without a history of cancer at baseline. We allow for gender
differences in the relationship between health care consumption
and BMI and WC status by gender-specific analysis. When
analyzing the relationship between future health care costs and
BMI and WC these explanatory variables were treated as
categorical and continuous variables, respectively.
Analysis based on BMI and WC as categorical
variables. BMI and WC were cross-tabulated to show the
distribution of subjects across the nine evaluated BMI/WC-
categories reflecting the nine possible combinations of WHO’s
three BMI categories (normal weight, overweight and obese) and
three WC categories (normal, increased and substantially
increased WC) [4]. For definitions of the WC and BMI
categories see Table 1.
To investigate whether the combined use of these measures
improves the identification of high costs persons, the annualized
mean health care costs were calculated for the nine different
combinations of BMI and WC categories. One way ANOVA
followed by Bonferroni’s post hoc test was used to compare the
means.
Analysis based on BMI and WC as continuous
variables. Ordinary least-squares (OLS) regression was used
to analyze the relationship between future health care cost and
BMI and WC. The dependent variable was the logarithm of future
health care costs. Costs were logged because preliminary
examination indicated that these data were characterized by a
skewed distribution with a long right hand tail as is frequently
observed for health care cost data (after the log conversion:
kurtosis=3.876; skewness=0.137).
Five Models were applied to investigate the relationship
between future health care costs and BMI and WC (separately
and combined). Model 1 and 2 test the relationship between future
health care costs and WC and BMI. In order to test whether
Table 1. WHO’s cut points for the classification of obesity
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and WC the interaction term BMI6WC was added to the
regressions in Model 3 and 4. In Model 3 the interaction term may
potentially capture any systematic impact that BMI status has on
the relationship between health care costs and WC. In Model 4 the
interaction term represents the possible impact that WC may have
on the cost-BMI relationship. There is reason to believe that BMI
only has a protective effect in the lower categories of WC and BMI
[1]. Therefore, the model specification applied in model 3 was run
on the subgroup of individuals with BMI ,30 kg/m
2 and WC
,88 cm for women and 102 cm for men (Model 5). The applied
obesity measures were all treated as continuous variables.
In order to adjust for potential confounding the following
potential explanatory variables were included in all Models: age,
income, level of education, smoking status and physical activity (a
dichotomous variable indicating none or some sports activities,
which in previous studies has proved to be the main predictor of
mortality among a broad panel of variables describing the physical
activity; Bigaard J et al, unpublished observation). Slope estimates
of these potential confounders are not reported in the results in
order to simplify the presentation of the key results.
The significance of each partial regression coefficient was
assessed using a two-sided Student-t test. Statistical significance
was set at p=0.05. Heteroscedasticity was evident and therefore
White-corrected standard errors were used [22]. Akaike’s
information criterion (AIC) was used for parsimonious goodness
of fit comparison of the Models. Pearson x
2 test was used to assess
statistical significance for categorical variables. Statistical analyses
were performed using STATA version 9.1.
Results
A total of 33,083 individuals visited a study clinic in the period
January 1996 to May 1997. After exclusion of those with missing
values the final sample constituted 31,840 individuals (97%):
15,334 men and 16,506 women. A total of 679 men and 402
women died during the period of observation. The number of
deaths amongst men differed significantly across the nine
combination categories of WC and BMI (p,0.001), while the
difference was not statistically significant for the women
(p=0.426).The baseline characteristics of the cohort are presented
in Table 2.
Figure 1 shows the mean health care cost per year per person
for each WC category over a period of seven years. For both
genders, the mean health care costs in the year of study entrance
were higher for those with substantially increased WC than for
those with increased WC (p,0.0001). Moreover, individuals with
increased WC have higher health care costs than those with
normal WC (p,0.0001). In general the mean cost per year
increase over the study period probably due to ageing of the
individuals. However, especially for men, the rise in health care
cost is more pronounced for those individuals with substantially
increased than for those with normal WC (p=0.0082) and those
with increased WC (p=0.0005). Similar trends were observed for
Table 2. Baseline characteristics of the 31,840 eligible participants with complete data (16,506 women and 15,334 men)
Women Men’s percentiles
Median 5 to 95 Percentile Range Median 5 to 95 Percentile Range
Age (years) 56 50 to 64 50 to 65 56 50 to 64 50 to 65
Weight (kg) 67.3 53.3 to 91.1 37.3 to 160 82 65.6 to 105 44 to 151
Height (cm) 164 154.5 to 174 128 to 192 177 166.5 to 188 141.5 to 206
Waist circumference (cm) 80.5 68 to 103 55 to 162 95 82 to 113 63 to 149
BMI (kg/m
2) 24.9 20.2 to 33.7 18.5 to 57.9 26.2 21.6 to 32.8 18.6 to 50.1
doi:10.1371/journal.pone.0002619.t002
Figure 1. Mean annual health care cost by WC categories (men black, women light).
doi:10.1371/journal.pone.0002619.g001
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Analysis based on categorization of BMI and WC. The
distribution of the subjects according to the nine combination
categories of WC and BMI are shown in Table 3. These
distributions show that in women with a normal WC 13.6% will
have a higher than normal BMI. Conversely, in women with an
increased or a substantially increased WC 36.5% and 6% will have
a normal BMI, respectively. In men with a normal WC 30.2%
have a higher BMI than normal, and in those who have a normal
BMI 15.7% and 1.1% have a increased or a substantially
increased WC. The two measurements scales clearly define
obese individuals differently. Note that the number of subjects in
extreme categories, such as individuals with high BMIs and
normal WCs (or vice versa), is very small which reduces our ability
to identify statistically significant differences in health care costs
across some categories due to lack of statistical power.
Table 4 shows the mean annual health care cost over the 7 year
observation period for the three BMI and WC categories,
respectively.
No statistically significant differences in costs were found for
different levels of BMI within a WC category (lowest p-
value=0.246), suggesting that the WC categorization adequately
captures the variation in health care costs. In contrast, information
on WC appears to capture variation in health care costs within
BMI categories. For women with a normal BMI a statistically
significant difference in mean cost was found between those with
normal WC and increased WC (p=0.025), and for both men and
women a statistically significant difference in means was obtained
between those with normal WC and substantially increased WC
(p=0.018 and p=0.006). In addition, for men and women with 25
kg/m
2#BMI ,30 kg/m
2 a significant difference in mean costs
was found between those with normal WC and substantially
increased WC (p,0.001), and between those with increased WC
and substantially increased WC (p,0.001).
These results indicate that for a given BMI category,
information on WC category increases the ability to predict
individual’s future health care costs, while for a given WC category
no additional information was gained by adding the BMI category.
Treating BMI and WC as continuous variables. The
results of the five regression Models are reported in Table 5. For
both men and women a highly statistically significant association
between future health care costs and WC (Model 1) and between
future health care costs and BMI (Model 2) was found (p,0.001).
Table 3. Distribution of the subjects according to the 3 waist circumference (WC) and 3 BMI categories, in combination.
Normal WC* Increased WC
* Substantially increased WC
* Total
No [%] No [%] No [%]
Women
BMI 18.5 to 24.9 kg/m
2 6619 [86.3] 1578 [36.5] 269 [6.0] 8466
BMI 25.0 to 29.9 kg/m
2 1038 [13.5] 2583 [59.8] 2137[47.3] 5758
BMI $30.0 kg/m
2 10 [0.1] 162 [3.7] 2110 [46.7] 2282
Total 7667 [100] 4323 [100] 4516 [100] 16,506
Men
BMI 18.5 to 24.9 kg/m
2 4501 [69.8] 778 [15.7] 42 [1.1] 5321
BMI 25.0 to 29.9 kg/m
2 1944 [30.1] 3968 [80.1] 1840 [46.8] 7752
BMI $30.0 kg/m
2 7 [0.1] 206 [4.2] 2048 [52.1] 2261
Total 6452 [100] 4952 [100] 3930 [100] 15,334
*Definition of the WC categories, see table 1.
doi:10.1371/journal.pone.0002619.t003
Table 4. Mean annual health care cost for the different BMI/WC categories (SD)*.
BMI/WC Total Normal WC
{ Increased WC
{ Substantially increased WC
{
Women
BMI 18.5 to 24.9 kg/m
2, $ 2049 1960 (63255) 2304 (64808) 2742 (63577)
BMI 25.0 to 29.9 kg/m
2, $ 2303 1969 (63480) 2164 (63349) 2632 (64206)
BMI .=30.0 kg/m
2, $ 2607 1097(6609) 2310 (63562) 2637 (63404)
Total 1960 (63284) 2221 (63950) 2641 (63813)
Men
BMI 18.5 to 24.9 kg/m
2, $ 2137 2053 (64631) 2476 (64703) 4799 (66936)
BMI 25.0 to 29.9 kg/m
2, $ 2247 1943 (64730) 2138 (63874) 2804 (64889)
BMI .=30.0 kg/m
2, $ 3131 2185 (61770) 2321 (63625) 3215 (66124)
Total 2020 (64659) 2199 (64007) 3039 (65595)
*One way ANOVA followed by Boferroni’s post hoc test was used to compare the means.
{Definition of the WC categories, see table 1.
doi:10.1371/journal.pone.0002619.t004
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suggests that BMI status does not systematically affect the WC-cost
relationship. However, in Model 5 (which is equivalent to Model 3
but only includes the subgroup of individuals with BMI,30 kg/
m
2 and WC ,88 cm for women and ,102 cm for men), the
interaction term is associated with a statistically significant
coefficient (p,0.01) for women. Contrary to Model 3 a
statistically significant coefficient of the interaction term was
found in Model 4, which demonstrates that inclusion of WC
information in addition to BMI status improves the prediction of
obesity related health costs.
In addition, Table 5 shows for both men and women that
Model 4 has the lowest AIC score. However, the small difference
in AIC values across the regression analysis which includes WC
only and the regression analysis which include BMI and WC*BMI
is so small that it does not support an argument for the latter. The
relative magnitude of the AIC estimates supports the finding that
the regressions including WC as an explanatory factor provide the
best fit to the data.
Table 5 confirms the findings from the analyses based on
categorisation of WC and BMI. Hence, no additional information
is gained by a combined use of BMI and WC for a given WC,
while for a given BMI the combined use of BMI and WC provides
additional information.
Discussion
The primary objective of this study was to investigate whether
the combined use of WC and BMI improves the identification of
high costs individuals. The present analysis complements a
previous study based on the same dataset which found that a
combination of WC and BMI strongly predicted all-cause
mortality, in both men and women [1]. Our hypotheses were
that: for all levels of BMI, increased WC implies added health care
costs (Hypothesis 1) and for a given WC increased BMI implies
reduced health care costs (Hypothesis 2).
The results based on the analysis where BMI and WC are
treated as continuous variables show that for a given BMI
inclusion of WC improves the identification of high costs
individuals, reflecting that a more abdominal fat distribution for
a given level of BMI gives higher health care costs. The
complementary analysis in which BMI and WC are treated as
categorical variables suggests the added value of WC is mainly
found amongst individual with BMI,30 kg/m
2, which corre-
sponds to the findings on mortality [1]. Figure 1 demonstrates that
future means costs are driven by differences in consumption of
health care costs at base-line as well as a difference in the rate of
increase in costs over the 7 year observation period.
The previous findings that BMI and WC have opposite effects
on total mortality when conditioned on each other [1], that fat
mass and lean body mass may have opposite effects on health [23]
and that WC captures the deleterious effects of fat mass on
mortality [24] have increased the interest in combining these two
measurements, thereby potentially achieving an increased accu-
racy in the identification of individuals at greatest risk. As in many
previous analyses, we find a strong positive correlation between
WC and BMI (0.87 for men, 0.86 for women). Despite this high
correlation between BMI and WC, the results show that the
categorization of individuals into risk groups according to their
obesity status differs between the two obesity measures. We
observe that WC is a more sensitive measure for capturing the
high cost individuals. Individuals with a normal BMI but increased
or substantially increased WC incur higher mean costs than those
with a normal BMI and a normal WC. Interestingly, this group
incurs significantly higher mean future health care costs than do
individuals who are overweight and obese but have a normal WC.
These results illustrate our general finding that WC is a better
predictor of future health care costs. This finding is in agreement
with a small study (n=424) which found that total health care
costs were better correlated with WC than with BMI [13]. The
findings are also in agreement with recent epidemiological studies
which indicate that WC is a stronger marker of health risk than
BMI is [25;26]. BMI has been criticized for misclassifying
muscular subjects as being overweight when, in fact, they are
lean [27] and it has been shown that the abdominal fat mass can
vary dramatically within a narrow range of BMI [4]. The fact that
WC is a good indicator of the location of the excess adipose tissue,
and that visceral fat seems to be highly related to health risk
[28;29] most likely explains this study’s observations.
One may, however, argue that the use of WHO’s categorization
may be suboptimal in this context since the WC and BMI cut-off
points were not designed to be used in combination. Rather, the
WC cut points were derived by use of BMI [28]. However, as
discussed above the categorization of individuals into risk groups
according to their obesity status differs between the two obesity
measures. Arder et al. [30] have in a recent study shown that the
optimal WC thresholds increased across BMI categories when
predicting future coronary events, and Bigaard et al. [31] have
found the same for total mortality. As also recently discussed by an
expert panel [32] these findings indicate that there is a need to
investigate whether it is necessary to develop special thresholds
when evaluating BMI and WC in combination. Furthermore, it
should be noted that despite the widely used recommendation of
the applied action levels of WC these are still under debate.
Our results show that BMI coupled with WC did not predict
obesity related health risk better than WC did alone. This finding
is in agreement with the findings in a previous study which found
that BMI coupled with WC did not predict obesity-related health
risk (measured by the odds ratios for different metabolic variables,
e.g. blood pressure and cholesterol) better than WC did alone
Table 5. The association between health care cost, BMI, WC
and BMI6WC. Note that constant term and potential
confounders are included in the analysis, but the estimates
are not reported
WC BMI WC6BMI Adjusted R
2 AIC
Women
Model 1 0.011*** 0.046 46,176
Model 2 0.022*** 0.041 46,274
Model 3 0.014*** 20.00005 0.046 46,176
Model 4 20.054*** 0.0005*** 0.047 46,162
Model 5
{ 0.017*** 20.0002** 0.035
Men
Model 1 0.017*** 0.079 47,672
Model 2 0.043*** 0.075 47,738
Model 3 0.013*** 0.00007 0.079 47,673
Model 4 20.056*** 0.0006*** 0.079 47,667
Model 5
{ 0.008* 0.00005 0.063
*,
** and
*** indicate statistical significance at the 5%, 1% and 0.1% level.
{Model 5 run the model specification applied in model 3 on the subgroup of
individuals with BMI,30 kg/m
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continuous scale [26]. However, when WC was dichotomized into
normal and high-risk categories, BMI remained a significant
predictor of health risk. The authors suggest that the reason for
this observation lies in the fact that when WC is treated as a
categorical variable whilst BMI is a continuous variable, BMI may
capture some of the variation in WC within a WC category. In
addition, in a recent article Han et al. conclude that due to the
large correlation between BMI and WC, a combination of the two
measures adds relatively little to the risk prediction [33].
Recently a panel composed of members with expertise in
obesity concluded that the current WC cut points are useless in a
clinical practice when BMI is already applied, and that more
useful WC cut points are recommended to be found [32].
According to our findings WC rather than BMI should be used.
In this study we have chosen to focus on all types of health care
consumption and not only health care consumption related to an a
priori specified disease associated with obesity such as diabetes and
cardio vascular diseases. A specific focus on one disease provides a
fragmented description of the disease profile of obese individuals.
Instead, we chose the non-discriminatory approach and focused
on all types of health care consumption in order to provide a fuller
description of the association between obesity status and need for
health care services. This strategy introduces a large degree of
variation in health care costs that may not be directly related to
obesity status. Consequently, the statistical models in table 5
produce R
2 values in the range 0.04 and 0.08. However, despite
this broad perspective and without focus on predefined specific
obesity related diseases we are still in position to show that WC is a
better predictor than BMI.
Zweifel and colleagues have previously proposed the so-called
‘red herrings’ hypothesis that proximity to death is a more
important predictor of health-care costs than is age [34]. Our
results support the red herrings hypothesis, as individuals who died
in the observation period incurred higher health care costs in the
year prior to death. To the extent that persons with high BMI
and/or high WC were more at risk of dying, they would on
average incur higher future costs. Amongst men, we found a
higher mortality amongst the obese (when defined in terms of WC
as well as BMI) hence proximity to death may be one of the drivers
underlying the observed higher rate of increased health care costs
amongst obese men. The differences in mean annual costs may in
this case overestimate potential cost savings associated with
reduction in obesity.
There are both strengths and limitations to this study. A major
strength is the large population sample (n=31,840), which ensures
sufficient power in the analyses. In addition, individual data on
health care consumption and associated cost were extracted from
valid registers and the anthropometric measurements were
measured by trained staff. Potential sources of bias and
confounding factors including illness-related weight losses were
sought eliminated with the exclusion of subjects with BMI under
18.5 kg/m
2 or with a history of cancer. Except for the cost data,
the analyses were based on cross-sectional data, implying only one
single measurement of WC and BMI, leaving information’s about
the WC and BMI status in the follow-up period missing. This
implies that the study results are based on associations of inter-
individual WC and BMI differences, and not intra-individual WC
and BMI changes on health care costs. Also, there is a risk of
selection bias, since only one-third (35%) of the invited individuals
participated in this study, and it is likely that in general it is the
healthier fraction who chose to participate in the study.
Conclusions
Our results show that combined use of WC and BMI increases
the prediction of high cost individuals, for a given BMI, reflecting
that a more abdominal fat distribution for a given BMI gives
higher health care costs. However, inclusion of BMI information
for a given WC only increases the prediction of future health cost
amongst women with BMI,30 kg/m
2 and WC ,88 cm.
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